Lymphangioleiomyomatosis, a Study on Cathepsin K

计划入组 19 人 · 首次发布于 2022 年 4 月 12 日

A Study to Examine the Effects of an Experimental Drug on Postmenopausal Osteoporosis (MK-0822-004)

计划入组 399 人 · 首次发布于 2005 年 6 月 3 日

A Study to Examine the Effects of an Experimental Drug on Women With Breast Cancer and Metastatic Bone Disease (MBD)(0822-016)(COMPLETED)

计划入组 43 人 · 首次发布于 2006 年 11 月 15 日

Cathepsin K Inhibitors(Glaxosmithkline Plc)

L-873724

AM-3876

KIM IVANA K

United States

K-Group Beta, Inc.

United States

K-PAX Pharmaceuticals, Inc.

United States

FDA Grants Medivir's MIV-711 Orphan Drug Designation for Osteogenesis Imperfecta Treatment

HDAC Inhibition in Muscle Cells Enhances Bone Regeneration via Extracellular Vesicles

Cathepsin C Inhibitor BI 1291583 Shows Promise in Reducing Bronchiectasis Exacerbations